{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T01:42:49Z","timestamp":1767145369010,"version":"build-2238731810"},"reference-count":25,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer\/Radioth\u00e9rapie"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.canrad.2021.09.004","type":"journal-article","created":{"date-parts":[[2021,12,22]],"date-time":"2021-12-22T19:40:19Z","timestamp":1640202019000},"page":"206-212","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Radiotherapy for laryngeal cancers"],"prefix":"10.1016","volume":"26","author":[{"given":"J.","family":"Biau","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Pointreau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Blanchard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Khampan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Giraud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Lapeyre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Maingon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.canrad.2021.09.004_bib0130","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1016\/S1278-3218(10)70007-X","article-title":"[Hypopharynx and larynx cancers: propositions for the selection and the delineation of peritumoral microscopic disease volumes (lymph nodes excluded)]","volume":"14","author":"Lapeyre","year":"2010","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2021.09.004_bib0135","first-page":"108","article-title":"Long-term results of a multicenter randomized phase III trial of induction chemotherapy with cisplatin, 5-fluorouracil, \u00b1docetaxel for larynx preservation","author":"Janoray","year":"2016","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.canrad.2021.09.004_bib0140","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1200\/JCO.2012.43.6097","article-title":"Long-term results of RTOG 91-11: a comparison of three nonsurgical treatment strategies to preserve the larynx in patients with locally advanced larynx cancer","volume":"31","author":"Forastiere","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2021.09.004_bib0145","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S1470-2045(11)70346-1","article-title":"Concomitant chemoradiotherapy versus acceleration of radiotherapy with or without concomitant chemotherapy in locally advanced head and neck carcinoma (GORTEC 99-02): an open-label phase 3 randomised trial","volume":"13","author":"Bourhis","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.canrad.2021.09.004_bib0150","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.1200\/JCO.2017.76.2591","article-title":"Induction chemotherapy followed by cetuximab radiotherapy is not superior to concurrent chemoradiotherapy for head and neck carcinomas: results of the GORTEC 2007-02 phase III randomized trial","volume":"36","author":"Geoffrois","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2021.09.004_bib0155","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1056\/NEJMoa032641","article-title":"Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer","volume":"350","author":"Bernier","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.canrad.2021.09.004_bib0160","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1080\/02841860802372272","article-title":"IMRT dose fractionation for head and neck cancer: variation in current approaches will make standardisation difficult","volume":"48","author":"Ho","year":"2009","journal-title":"Acta Oncol"},{"key":"10.1016\/j.canrad.2021.09.004_bib0165","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0360-3016(03)00405-X","article-title":"Intensity-modulated radiation therapy for head-and-neck cancer: the UCSF experience focusing on target volume delineation","volume":"57","author":"Lee","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2021.09.004_bib0170","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S1470-2045(10)70290-4","article-title":"Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial","volume":"12","author":"Nutting","year":"2011","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.canrad.2021.09.004_bib0175","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/j.ijrobp.2009.04.011","article-title":"Multi-institutional trial of accelerated hypofractionated intensity-modulated radiation therapy for early-stage oropharyngeal cancer (RTOG 00-22)","volume":"76","author":"Eisbruch","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2021.09.004_bib0180","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.ijrobp.2017.03.050","article-title":"Patterns of care for patients with early-stage glottic cancer undergoing definitive radiation therapy: a National Cancer Database analysis","volume":"98","author":"Stokes","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2021.09.004_bib0185","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.ijrobp.2017.02.218","article-title":"Final report of a prospective randomized trial to evaluate the dose\u2013response relationship for postoperative radiation therapy and pathologic risk groups in patients with head and neck cancer","volume":"98","author":"Rosenthal","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2021.09.004_bib0190","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.oraloncology.2018.10.034","article-title":"Target volume selection and delineation (T and N) for primary radiation treatment of oral cavity, oropharyngeal, hypopharyngeal and laryngeal squamous cell carcinoma","volume":"87","author":"Gr\u00e9goire","year":"2018","journal-title":"Oral Oncol"},{"key":"10.1016\/j.canrad.2021.09.004_bib0195","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.radonc.2017.10.016","volume":"126","author":"Gr\u00e9goire","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2021.09.004_bib0200","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.ijrobp.2008.11.059","article-title":"Clinical practice guidance for radiotherapy planning after induction chemotherapy in locoregionally advanced head-and-neck cancer","volume":"75","author":"Salama","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2021.09.004_bib0205","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.canrad.2005.05.003","article-title":"[Building clinical target volume in laryngeal cancers using knowledge about modes of invasion of each location]","volume":"9","author":"Bidault","year":"2005","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2021.09.004_bib0210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.radonc.2019.01.018","article-title":"Selection of lymph node target volumes for definitive head and neck radiation therapy: a 2019 Update","volume":"134","author":"Biau","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2021.09.004_bib0215","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.radonc.2013.10.010","article-title":"Delineation of the neck node levels for head and neck tumors: a 2013 update. DAHANCA, EORTC, HKNPCSG, NCIC CTG, NCRI, RTOG, TROG consensus guidelines","volume":"110","author":"Gr\u00e9goire","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2021.09.004_bib0220","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1002\/hed.1144","article-title":"Cervical nodal metastases in squamous cell carcinoma of the head and neck: what to expect","volume":"23","author":"Mukherji","year":"2001","journal-title":"Head Neck"},{"key":"10.1016\/j.canrad.2021.09.004_bib0225","doi-asserted-by":"crossref","first-page":"952","DOI":"10.3109\/00016489.2014.920109","article-title":"Management of cervical lymph nodes for cN0 advanced glottic laryngeal carcinoma and its long-term results","volume":"134","author":"Ma","year":"2014","journal-title":"Acta Otolaryngol"},{"key":"10.1016\/j.canrad.2021.09.004_bib0230","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1177\/019459989310800102","article-title":"Paratracheal lymph node dissection for carcinoma of the larynx, hypopharynx, and cervical esophagus","volume":"108","author":"Weber","year":"1993","journal-title":"Otolaryngol\u2013Head Neck Surg"},{"key":"10.1016\/j.canrad.2021.09.004_bib0235","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.radonc.2018.04.020","article-title":"Implications of improved diagnostic imaging of small nodal metastases in head and neck cancer: Radiotherapy target volume transformation and dose de-escalation","volume":"128","author":"van den Bosch","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2021.09.004_bib0240","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.radonc.2006.03.009","article-title":"Proposal for the delineation of the nodal CTV in the node-positive and the post-operative neck","volume":"79","author":"Gr\u00e9goire","year":"2006","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2021.09.004_bib0245","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.canrad.2014.06.013","article-title":"[Delineation of the lymph nodes for head neck cancers]","volume":"18","author":"Lapeyre","year":"2014","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2021.09.004_bib0250","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.radonc.2015.07.041","article-title":"CT-based delineation of organs at risk in the head and neck region: DAHANCA, EORTC, GORTEC, HKNPCSG, NCIC CTG, NCRI, NRG Oncology and TROG consensus guidelines","volume":"117","author":"Brouwer","year":"2015","journal-title":"Radiother Oncol"}],"updated-by":[{"DOI":"10.1016\/j.canrad.2022.04.001","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000}}],"container-title":["Cancer\/Radioth\u00e9rapie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321821002456?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321821002456?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,2,9]],"date-time":"2022-02-09T13:47:05Z","timestamp":1644414425000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1278321821002456"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":25,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["S1278321821002456"],"URL":"https:\/\/doi.org\/10.1016\/j.canrad.2021.09.004","relation":{},"ISSN":["1278-3218"],"issn-type":[{"value":"1278-3218","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Radiotherapy for laryngeal cancers","name":"articletitle","label":"Article Title"},{"value":"Cancer\/Radioth\u00e9rapie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canrad.2021.09.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Masson SAS on behalf of Soci\u00e9t\u00e9 fran\u00e7aise de radioth\u00e9rapie oncologique (SFRO).","name":"copyright","label":"Copyright"}]}}